Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung Cancer.
Authors: Edwards DM; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Schonewolf CA; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Rice JD; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan., Schipper M; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan., Haken RKT; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Matuszak M; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Balter J; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Jarema D; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Arenberg DA; Department of Medicine, Pulmonology, University of Michigan, Ann Arbor, Michigan., Piert M; Department of Radiology, University of Michigan, Ann Arbor, Michigan., Qin A; Department of Medicine, Hematology-Oncology, University of Michigan, Ann Arbor, Michigan., Kalemkerian GP; Department of Medicine, Hematology-Oncology, University of Michigan, Ann Arbor, Michigan., Schneider BJ; Department of Medicine, Hematology-Oncology, University of Michigan, Ann Arbor, Michigan., Ramnath N; Department of Medicine, Hematology-Oncology, University of Michigan, Ann Arbor, Michigan; Section of Hematology Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan., Chapman CH; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; Department of Radiation Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan; Department of Radiation Oncology, Baylor College of Medicine, Houston, Texas., Elliott DA; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; Department of Radiation Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan., Lawrence TS; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Hearn J; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Hayman JA; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Jolly S; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. Electronic address: shrutij@med.umich.edu.
Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Dec 01; Vol. 120 (5), pp. 1332-1343. Date of Electronic Publication: 2024 Jul 04.
Publication Type: Journal Article; Clinical Trial, Phase II
Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-355X
DOI:10.1016/j.ijrobp.2024.06.018